24.26
Schlusskurs vom Vortag:
$23.25
Offen:
$23.91
24-Stunden-Volumen:
496.94K
Relative Volume:
0.88
Marktkapitalisierung:
$1.19B
Einnahmen:
$3.18B
Nettoeinkommen (Verlust:
$24.08M
KGV:
53.19
EPS:
0.4561
Netto-Cashflow:
$104.49M
1W Leistung:
-2.61%
1M Leistung:
+29.18%
6M Leistung:
-18.67%
1J Leistung:
-16.90%
Astrana Health Inc Stock (ASTH) Company Profile
Firmenname
Astrana Health Inc
Sektor
Branche
Telefon
(626) 282-0288
Adresse
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
24.26 | 1.14B | 3.18B | 24.08M | 104.49M | 0.4561 |
|
HCA
Hca Healthcare Inc
|
532.97 | 119.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
227.63 | 19.54B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.71B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.71 | 12.11B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
192.42 | 11.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | Needham | Buy |
| 2025-04-01 | Eingeleitet | Barclays | Equal Weight |
| 2024-10-14 | Eingeleitet | TD Cowen | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Hochstufung | Truist | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-26 | Eingeleitet | Jefferies | Buy |
| 2024-02-22 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-24 | Eingeleitet | Stifel | Buy |
| 2023-12-22 | Eingeleitet | Truist | Hold |
| 2023-10-17 | Eingeleitet | BTIG Research | Buy |
| 2023-04-12 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-19 | Eingeleitet | Lake Street | Buy |
| 2022-09-21 | Eingeleitet | William Blair | Outperform |
| 2022-01-11 | Fortgesetzt | Colliers Securities | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $38Astrana Health (NASDAQ:ASTH) - Benzinga
Astrana Health, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Truist raises Astrana Health stock price target on earnings update - Investing.com
OBBBA Threatens Astrana Health’s Revenue as Tighter Eligibility Rules Shrink Federally Funded Patient Base - TipRanks
Decoding Astrana Health Inc (ASTH): A Strategic SWOT Insight - GuruFocus
A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns - simplywall.st
Astrana Health reports $3.18B revenue, $0.46 EPS in 10-K - TradingView
Astrana Health CEO Sees 20%-30% Growth in 2026 Despite Regulatory Volatility at Barclays Conference - Yahoo Finance
Can Astrana Health Inc sustain earnings growthMarket Growth Report & Momentum Based Trading Signals - baoquankhu1.vn
Top 5% for patient safety: inside Foothill Regional's 2026 Healthgrades win - Stock Titan
Astrana Health (NASDAQ:ASTH) Shares Down 4.9%Here's Why - MarketBeat
Astrana Health, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Astrana Health (ASTH) Is Up 22.5% After Earnings Beat, Buyback Boost and 10-K DelayHas The Bull Case Changed? - Sahm
Astrana Health initiated as buy at Needham on valuation - MSN
Investment Report: Is Astrana Health Inc a cyclical or defensive stockJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
Astrana Health Updates Investor Presentation on Value-Based Strategy - The Globe and Mail
Astrana Health, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations - Markets Mojo
Royce & Associates LP Reduces Stock Holdings in Astrana Health, Inc. $ASTH - MarketBeat
ASTH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Astrana Health (ASTH) Still Attractive After The Recent 28% Weekly Price Jump - simplywall.st
Vanguard Group Inc. Sells 112,308 Shares of Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health : Investor Presentation – March 2026 - marketscreener.com
Astrana Health updates corporate presentation, reiterates FY2026 revenue $3.8–4.1B and Adj. EBITDA $250–280M guidance - TradingView
Astrana Health (NASDAQ: ASTH) issues 2026 growth guidance and flags control weakness - Stock Titan
Cigna CEO Cordani To Retire, Successor Named At Bloomfield-Based Health Care Giant - AOL.com
Astrana Health (ASTH +29%): Massive EPS Beat & Strong 2026 Guidance Ignites Rally - Trefis
Astrana Health to Attend Investor Conferences in March 2026 - geneonline.com
Doctor-focused Astrana Health lines up five investor talks in March - Stock Titan
Astrana Health Posts Upbeat Q4 Earnings, Joins AeroVironment, Kratos Defense & Security Solutions And Other Big Stocks Moving Higher On Monday - Sahm
Astrana Health Inc. (ASTH) - DirectorsTalk Interviews
Astrana Health Juggles Profit Turnaround Buybacks And 10 K Delay - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), OmniAb (OABI) and Astrana Health (ASTH) - The Globe and Mail
Needham raises Astrana Health stock price target to $30 on outlook - Investing.com UK
Astrana Health raises share repurchase authorization to $100M - TipRanks
Astrana Health reports Q4 adjusted EPS 54c, consensus 33c - TipRanks
Astrana Health Earnings Call Balances Records and Risks - TipRanks
Astrana Health (ASTH) Margins Stay Near 1% And Test Bullish Earnings Narratives - simplywall.st
Why Astrana Health (ASTH) Stock Is Up Today - Yahoo Finance
Top Midday Gainers - marketscreener.com
Astrana Health, Inc. Provides Revenue Guidance for the Three Months Ending March 31, 2026 and for Year Ending December 31, 2026 - marketscreener.com
Astrana Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Astrana Health Q4 2025 Earnings: Revenue Exceeds Expectations, 2026 GuidanceNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Earnings call transcript: Astrana Health Q4 2025 beats EPS forecast, stock surges - Investing.com Canada
Astrana Health Q4 Earnings Call Highlights - Yahoo Finance
Astrana Health (NASDAQ:ASTH) Shares Gap Up After Strong Earnings - MarketBeat
Astrana Health (ASTH) Q4 2025 Earnings Transcript - AOL.com
Astrana Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Astrana Health Delays Filing of Annual Report - TipRanks
Astrana Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-03-02 - Seeking Alpha
Astrana Health (NASDAQ: ASTH) delays 2025 Form 10-K; expects material weakness disclosure - Stock Titan
Finanzdaten der Astrana Health Inc-Aktie (ASTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Astrana Health Inc-Aktie (ASTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):